Riskpilot← Back to searchSign inGet full accessDERMAPHARM HOLDING A/S
A/SActiveCVR 32645577Europavej 10Activities of holding companies · NACE 6421Est. 2009— employees
Revenue 2024
—
EBITDA margin
—
+151960% vs 2023
Equity ratio
96.2%
Financial strength
Net profit 2024
DKK 18,4M
+85% vs 2023
| Revenue | — | — |
| EBITDA | DKK 18,5M | +151960% |
| Net profit | DKK 18,4M | +85% |
| Total assets | DKK 66M | +26% |
| Equity | DKK 63,5M | +27% |
| Employees | — | — |
Legal name
DERMAPHARM HOLDING A/S
CVR number
32645577
Legal form
Aktieselskab
NACE code
6421 · Activities of holding companies
Founded
1. december 2009
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, af den samlede direktion, af bestyrelsesformanden i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at være holdingselskab og drive hermed beslægtet virksomhed
Address
Europavej 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -5 | -6 | -19 | -6 | -42 | -53 | -8 | -12 | -8 | -7 | -7 | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -6 | -19 | -6 | -42 | -53 | -8 | -12 | -8 | -7 | -7 | -12 | 18.506 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -6 | -19 | -6 | -42 | -53 | -8 | -12 | -8 | -7 | -7 | -12 | 18.506 |
| Net financials | 985 | 3.532 | -4.596 | 4.076 | 7.619 | 8.455 | 4.664 | 6.142 | 11.693 | 7.727 | 6.892 | 9.982 | 18.932 |
| Profit before tax | 980 | 3.525 | -4.614 | 4.070 | 7.576 | 8.402 | 4.656 | 6.130 | 11.685 | 7.719 | 6.885 | 9.970 | 18.425 |
| Tax | -23 | -49 | -58 | -45 | -69 | -68 | -65 | -62 | -69 | -41 | -28 | -12 | -22 |
| Net profit | 1.003 | 3.574 | -4.556 | 4.115 | 7.646 | 8.470 | 4.721 | 6.192 | 11.754 | 7.761 | 6.913 | 9.981 | 18.447 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 15.734 | 14.805 | 10.496 | 14.871 | 23.304 | 32.303 | 32.752 | 35.449 | 42.618 | 42.445 | 45.678 | 52.352 | 65.999 |
| Equity | 9.415 | 8.548 | 3.992 | 8.107 | 15.753 | 24.223 | 25.145 | 27.537 | 35.490 | 39.451 | 42.564 | 50.045 | 63.493 |
| Long-term debt | 0 | 0 | 0 | 0 | 7.030 | 7.310 | 7.603 | 7.907 | 0 | 0 | 0 | 2.000 | 2.000 |
| Short-term debt | 6.318 | 6.256 | 6.504 | 6.764 | 522 | 769 | 5 | 5 | 7.127 | 2.994 | 3.114 | 306 | 506 |
| Total debt | 6.318 | 6.256 | 6.504 | 6.764 | 7.551 | 8.080 | 7.608 | 7.912 | 7.127 | 2.994 | 3.114 | 2.306 | 2.506 |
EBITDA margin
1850560400.0%
This company
15.8%
Market median
+11712407495% vs market
20122024
Equity ratio
96.2%
This company
38.2%
Market median
+152% vs market
20122024
Return on equity
29.1%
This company
18.4%
Market median
+58% vs market
20122024
Net profit margin
1844721700.0%
This company
8.1%
Market median
+22774341875% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PB Management | Management | 2025 | — | — |
ME Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
BK Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2009 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sunshine BidCo ApS | Company | 100.0% | 100.0% | 2025 |
BENAVIMIRI HOLDING ApS | Company | 20.0% | 20.0% | 2017 |
KUNTKES HOLDING ApS | Company | 66.7% | 66.7% | 2018 |
HOLDINGSELSKABET AF 15. FEBRUAR 2018 A/S | Company | 66.7% | 66.7% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sunshine TopCo ApS
DERMAPHARM HOLDING A/S Board members of DERMAPHARM HOLDING A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Bogh | Management | 0 companies |
| Mikkel Egelund Jensen | Chief Executive Officer | 0 companies |
| Birger Kuntkes | Chief Executive Officer | 0 companies |
| Massimiliano Costantini | Board of Directors | 0 companies |
| Steen Andersen | Board of Directors | 0 companies |
| Magdalena Jurkiewicz | Board of Directors | 0 companies |
| Thomas Dimitri Jacquemet | Board of Directors | 0 companies |
| Marie Anne Louise Bozec | Board of Directors | 0 companies |
| Jean-Yves Paul Etienne Desmottes | Chairman | 0 companies |
| Erik Friedlænder | Chairman | 0 companies |
| Annette Kuntkes | Board of Directors | 0 companies |